Millennium Management’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-39,140
| Closed | -$77.1K | – | 6681 |
|
|
2024
Q3 | $77.1K | Buy |
+39,140
| New | +$149K | ﹤0.01% | 5625 |
|
|
2023
Q4 | – | Sell |
-452
| Closed | -$9.98K | – | 6692 |
|
|
2023
Q3 | $9.98K | Buy |
452
+161
| +55% | +$4.2K | ﹤0.01% | 5763 |
|
|
2023
Q2 | $2.06K | Buy |
291
+30
| +11% | +$691 | ﹤0.01% | 5950 |
|
|
2023
Q1 | $12K | Buy |
+261
| New | +$28.5K | ﹤0.01% | 5990 |
|
|
2022
Q3 | – | Sell |
-91
| Closed | -$73K | – | 7628 |
|
|
2022
Q2 | $73K | Sell |
91
-2
| -2% | -$2.96K | ﹤0.01% | 6051 |
|
|
2022
Q1 | $243K | Sell |
93
-88
| -49% | -$187K | ﹤0.01% | 5723 |
|
|
2021
Q4 | $467K | Sell |
181
-143
| -44% | -$497K | ﹤0.01% | 5111 |
|
|
2021
Q3 | $1.48M | Sell |
324
-409
| -56% | -$2.06M | ﹤0.01% | 4251 |
|
|
2021
Q2 | $4.36M | Buy |
733
+196
| +36% | +$1.27M | ﹤0.01% | 2931 |
|
|
2021
Q1 | $4.35M | Buy |
537
+274
| +104% | +$2.9M | ﹤0.01% | 2732 |
|
|
2020
Q4 | $1.63M | Buy |
263
+222
| +541% | +$1.36M | ﹤0.01% | 3396 |
|
|
2020
Q3 | $276 | Buy |
41
+26
| +173% | +$193K | ﹤0.01% | 3889 |
|
|
2020
Q2 | $95K | Buy |
+15
| New | +$63.7K | ﹤0.01% | 3981 |
|
|
2020
Q1 | – | Sell |
-35
| Closed | -$202K | – | 4654 |
|
|
2019
Q4 | $202K | Sell |
35
-11
| -24% | -$104K | ﹤0.01% | 3879 |
|
|
2019
Q3 | $568K | Sell |
46
-80
| -63% | -$642K | ﹤0.01% | 3181 |
|
|
2019
Q2 | $1.05M | Buy |
+126
| New | +$1.48M | ﹤0.01% | 2779 |
|
|
2018
Q4 | – | Sell |
-111
| Closed | -$4.12M | – | 4283 |
|
|
2018
Q3 | $4.12M | Sell |
111
-124
| -53% | -$4.08M | 0.01% | 1949 |
|
|
2018
Q2 | $9.11M | Buy |
235
+178
| +312% | +$6.76M | 0.01% | 1387 |
|
|
2018
Q1 | $1.86M | Buy |
57
+30
| +111% | +$808K | ﹤0.01% | 2362 |
|
|
2017
Q4 | $564K | Sell |
27
-18
| -40% | -$372K | ﹤0.01% | 3028 |
|
|
2017
Q3 | $938K | Buy |
45
+7
| +18% | +$130K | ﹤0.01% | 2556 |
|
|
2017
Q2 | $611K | Buy |
38
+14
| +58% | +$280K | ﹤0.01% | 2708 |
|
|
2017
Q1 | $620K | Sell |
24
-3
| -11% | -$84.4K | ﹤0.01% | 2689 |
|
|
2016
Q4 | $701K | Buy |
+27
| New | +$832K | ﹤0.01% | 2463 |
|
|
2016
Q1 | – | Sell |
-51
| Closed | -$2.77M | – | 3752 |
|
|
2015
Q4 | $2.77M | Buy |
51
+14
| +38% | +$755K | 0.01% | 1725 |
|
|
2015
Q3 | $1.64M | Sell |
37
-26
| -41% | -$1.73M | ﹤0.01% | 2038 |
|
|
2015
Q2 | $5.08M | Buy |
63
+42
| +200% | +$3.64M | 0.01% | 1388 |
|
|
2015
Q1 | $1.64M | Buy |
+21
| New | +$1.95M | ﹤0.01% | 2066 |
|
Other funds holding TTOO
VF
TSS
Millennium Management's TTOO Position: Q4 2024 in Review
Millennium Management sold out of T2 Biosystems, Inc (TTOO) in Q4 2024, closing a stake of 39,140 shares — an estimated $77.1K sold.
Millennium Management first reported a position in TTOO in Q1 2015 and held it in 28 quarters. The position peaked at $9.11M in Q2 2018. 26 funds tracked by Wall St. Rank hold TTOO as of Q4 2024.
- Millennium Management reported no remaining T2 Biosystems, Inc position as of Q4 2024 after selling out during the quarter.
- Millennium Management sold 39,140 T2 Biosystems, Inc shares in Q4 2024, an estimated $77.1K.
- Millennium Management first reported a position in T2 Biosystems, Inc in Q1 2015 and held it in 28 quarters.
- Millennium Management's T2 Biosystems, Inc position peaked at $9.11M in Q2 2018.
- 26 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2024.
Based on Millennium Management's 13F filing for Q4 2024, filed 14 Feb 2025.